Doronichev: Google Stadia failed due to a lack of organizational focus
Andrey Doronichev · Driving Efficiency in Biotech Research with Andrey Doronichev of BIOPTIC | The Innovators & Investors Podcast · Apr 14, 2026 · at 9:23
Andrey Doronichev, former Google product director who led the launch of Stadia and is now CEO of Bioptic, discusses why Google's cloud gaming platform shut down.
0:00 / 0:08exact quote · 8.7s
720p mp4 · rendered on demand · StarZero watermark
“Google didn't have enough attention to focus on this project. It didn't have enough resources to dedicate to it. And as a result, it failed despite, you know, all the resources.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Andrey Doronichev
Doronichev: Every pharma company will become AI-native within 10 years or fail
“Within the next 10 years, every pharma will become an AI native pharma. Just like every retailer turned into e-commerce or left the market within the first 10 years of the internet.”
Doronichev: Scientific research is not the primary bottleneck in pharma commercialization
“Science is not really a bottleneck in, in most cases. Getting, there's plenty of great research out there, and there are many ways researchers are discovering molecules, but getting from a great research paper to an actual drug that helps treat patients and ge…”
Doronichev: Fully automated AI hedge funds will emerge to trade biotech
“I believe this is going to happen. We're going to have fully automated end-to-end first probably hedge funds or investment companies that would be full in the fully automated fashion, deeply analyzing scientific and business details of companies out there and …”
Doronichev: Consumer AI models fall short for multi-million-dollar life science decisions
“Those are consumer grade AI systems that make a lot of our tasks easier, right? But when it comes to business and especially life sciences business applications, they often come short. Specifically there are special metrics in AI world, precision, recall hallu…”
Doronichev: YouTube App's Success Was Driven Primarily by Underlying ML
“I think the major reason this product became so successful had to do with machine learning infrastructure that was completely under the surface and really hard to see.”
Doronichev: Scientific Papers Enable Startups to Bypass Biopharma Relationship Networks
“So I guess the lesson for fellow founders here, yes, you might be disadvantaged in terms of, you know, whether or not you play golf with the CEO of Pfizer and it might feel like it's impossible to penetrate this big pharma world. However, if your research matt…”